Vinva Investment Management Ltd Boosts Stake in Eli Lilly

The institutional investor increased its position in the pharmaceutical company by 25.7% in the third quarter.

Published on Mar. 8, 2026

Vinva Investment Management Ltd raised its stake in Eli Lilly and Company (NYSE:LLY) by 25.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor now owns 62,653 shares of the company's stock after acquiring an additional 12,819 shares during the period.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, developing and marketing a wide range of medications. Institutional investors like Vinva closely monitor and adjust their positions in Lilly, as the company's performance can significantly impact their overall investment portfolios.

The details

Vinva Investment Management Ltd's holdings in Eli Lilly and Company were worth $45,518,000 at the end of the most recent reporting period. The company's stake in Lilly now accounts for approximately 0.9% of Vinva's portfolio, making it the 13th largest position.

  • Vinva Investment Management Ltd increased its stake in Eli Lilly during the 3rd quarter of 2026.

The players

Vinva Investment Management Ltd

An institutional investor that manages a portfolio of investments, including a position in pharmaceutical company Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly researches, develops, manufactures, and commercializes a broad range of medicines and therapies for patients worldwide.

Got photos? Submit your photos here. ›

The takeaway

Vinva Investment Management's increased stake in Eli Lilly reflects the pharmaceutical company's continued importance and performance in the eyes of major institutional investors. As a leading global drug maker, Lilly's stock movements and business developments are closely watched by the investment community.